SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging following a preliminary business update that revealed record-breaking demand, with over $60 billion in new orders and a significant doubling of gross margin guidance. The community is actively debating the potential for a massive short squeeze given the high volume of short interest and the sudden shift in fundamentals that has caught many bearish positions off-guard.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is drawing intense community focus following its latest earnings report, where a massive order backlog and raised financial guidance highlighted its pivotal role in meeting the surging electricity demand from AI data centers. While some investors see the stock's recent volatility as a strategic buying opportunity, others are actively debating whether its rapid rise is sustainable as the market gauges the company's ability to convert its energy infrastructure projects into immediate, high-margin revenue.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is seeing heightened volatility as investors weigh the stock's significant decline against the potential competitive threat posed by SpaceX's Starlink expansion. While the community remains divided on whether this is a long-term value opportunity bolstered by a safe dividend or a value trap susceptible to further structural disruption, many are actively debating its technical oversold status heading into the next earnings release.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently in the spotlight following the formalization of a multi-year partnership with Virgin Atlantic to launch electric air taxi services in the UK, a development that community members are monitoring closely for its impact on international expansion and operational scaling. While some investors remain cautious about long-term cash burn and regulatory timelines, discussions are heavily centered on the stock's potential as a leader in the eVTOL sector and the strategic significance of its manufacturing alliance with Toyota.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors closely monitor reports of delayed Gemini model releases and the company's massive AI infrastructure spending, while balancing these concerns against its search dominance and cloud growth. The community remains divided, with some concerned over internal capacity constraints and valuation resets, while others view the stock as a critical AI powerhouse that is increasingly integrated into the global infrastructure layer.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is trending as investors react to a record-breaking earnings report that highlighted massive revenue growth and a user base exceeding 135 million customers, even as some expressed concern over rising credit provisions. Meanwhile, community sentiment remains highly bullish, with many viewing the post-earnings volatility as an opportunity to accumulate shares in a rapidly scaling digital banking platform.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is generating significant buzz as traders closely monitor a steady ramp-up in aircraft deliveries and major order wins, all while debating the stock's long-term valuation against its recent price volatility. Community sentiment remains polarized, with many investors aggressively buying the dip in anticipation of an earnings-driven breakout, while others voice deep frustration over persistent execution headwinds and recent media-driven selling pressure.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is currently the focal point of intense investor debate as the market weighs strong clinical data for its lead oncology asset, ivonescimab, against significant volatility and concerns over future financing. Community discussion is dominated by reactions to the HARMONi clinical trial results and upcoming regulatory milestones, with many investors closely tracking insider accumulation by leadership as a signal of long-term conviction.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc. is trending as investors debate its valuation and potential growth, while the community focuses on its AI data licensing prospects versus ongoing concerns regarding platform moderation and user growth sustainability. The conversation is further fueled by high-conviction retail discussions and technical speculation about potential breakouts and short-term volatility.

Tidal Trust II - Defiance Daily Target 2X Short MU ETF

MUZ is trending as investors weigh concerns about the long-term sustainability of the memory semiconductor market, including potential supply competition and infrastructure constraints for AI data centers. Community discussion is heavily divided between those hedging with leveraged short positions against Micron and those maintaining bullish outlooks based on reported revenue growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Maxim Says Context Therapeutics (CNTX)'s Share Pullback Is an Overreaction; Remains Bullish

Maxim Says Context Therapeutics (CNTX)'s Share Pullback Is an Overreaction; Remains Bullish...

CNTX Hits Worst Day In History After Ovarian Cancer Trial Data — But Analysts See Buying Opportunity In Dip

Equity

The Philadelphia biotech reported data from 21 patients with advanced CLDN6-positive solid tumors, including 14 with platinum-resistant ovarian cancer.


Context Therapeutics (NASDAQ:CNTX) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Context Therapeutics (NASDAQ:CNTX - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.03...

Context Therapeutics (CNTX) to Release Quarterly Earnings on Wednesday

Context Therapeutics (NASDAQ:CNTX) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...

Context Therapeutics (NASDAQ:CNTX)  Shares Down 7%   - Time to Sell?

Context Therapeutics (NASDAQ:CNTX) Shares Down 7% - Here's What Happened...

Neogen Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary

Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced the appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary. Ms. Stacey is an accomplished chief legal and compliance officer and board secretary with extensive...

Context Therapeutics (NASDAQ:CNTX) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded Context Therapeutics from a "hold" rating to a "sell" rating in a report on Sunday...

Context Therapeutics Inc. (NASDAQ:CNTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Context Therapeutics Inc. (NASDAQ:CNTX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine research firms that are currently covering the stock, MarketBeat...

Q1 EPS Forecast for Context Therapeutics Lowered by Analyst

Context Therapeutics Inc. (NASDAQ:CNTX - Free Report) - Equities research analysts at Lifesci Capital reduced their Q1 2026 earnings per share estimates for Context Therapeutics in a report issued on...

HC Wainwright Brokers Reduce Earnings Estimates for CNTX

Context Therapeutics Inc. (NASDAQ:CNTX - Free Report) - Research analysts at HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates for Context Therapeutics in a research report...

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. The firm's robust clinical program for candidate onapristone extended release (ONA-XR) comprises three Phase 2 clinical trials and one Phase 1b/2 clinical trial in hormone-driven breast, ovarian and endometrial cancer, as well as two Phase 0 biomarker pharmacodynamic trials in breast cancer. Its ONA-XR is a novel, first-in-class small molecule under development as a complete antagonist of the progesterone receptor, a key unchecked mechanism in hormone-driven women?s cancers. The company was founded by Martin Lehr and Felix Kim in April 2015 and is headquartered in Philadelphia, PA.

Context Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

CNTXContext Therapeutics Inc

Latest CNTX News